TPCW
TMO icon

TD Private Client Wealth’s Thermo Fisher Scientific TMO Stock Holding History

TD Private Client Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.11M Buy
10,400
+870
+9% +$472K 0.11% 129
2025
Q4 		$5.52M Buy
9,530
+4,505
+90% +$2.55M 0.12% 117
2025
Q3 		$2.44M Buy
5,025
+187
+4% +$87K 0.05% 217
2025
Q2 		$1.96M Sell
4,838
-2,712
-36% -$1.13M 0.05% 243
2025
Q1 		$3.76M Buy
7,550
+1,332
+21% +$721K 0.1% 139
2024
Q4 		$3.23M Sell
6,218
-1,931
-24% -$1.06M 0.09% 165
2024
Q3 		$5.04M Buy
8,149
+1,591
+24% +$942K 0.15% 107
2024
Q2 		$3.63M Buy
6,558
+167
+3% +$95.7K 0.11% 136
2024
Q1 		$3.71M Buy
6,391
+369
+6% +$207K 0.12% 137
2023
Q4 		$3.2M Sell
6,022
-475
-7% -$230K 0.12% 146
2023
Q3 		$3.29M Sell
6,497
-2,444
-27% -$1.3M 0.14% 142
2023
Q2 		$4.66M Sell
8,941
-2,268
-20% -$1.22M 0.2% 111
2023
Q1 		$6.46M Sell
11,209
-1,394
-11% -$786K 0.29% 73
2022
Q4 		$6.97M Sell
12,603
-2,604
-17% -$1.38M 0.33% 60
2022
Q3 		$7.73M Buy
15,207
+366
+2% +$205K 0.4% 48
2022
Q2 		$8.08M Sell
14,841
-416
-3% -$229K 0.39% 48
2022
Q1 		$9.02M Buy
15,257
+551
+4% +$317K 0.38% 50
2021
Q4 		$9.81M Sell
14,706
-4,505
-23% -$2.81M 0.41% 48
2021
Q3 		$11M Sell
19,211
-873
-4% -$479K 0.47% 41
2021
Q2 		$10.1M Sell
20,084
-2,172
-10% -$1.02M 0.43% 46
2021
Q1 		$10.2M Buy
22,256
+686
+3% +$327K 0.47% 42
2020
Q4 		$10M Sell
21,570
-523
-2% -$245K 0.51% 40
2020
Q3 		$9.75M Sell
22,093
-226
-1% -$93.4K 0.55% 37
2020
Q2 		$8.09M Buy
22,319
+7,074
+46% +$2.37M 0.47% 46
2020
Q1 		$4.32M Sell
15,245
-1,284
-8% -$405K 0.31% 74
2019
Q4 		$5.37M Buy
+16,529
New +$5.01M 0.32% 75

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TD Private Client Wealth's TMO Position: Q1 2026 in Review

TD Private Client Wealth increased its Thermo Fisher Scientific (TMO) stake by 9.1% in Q1 2026, buying an estimated $472K and bringing the position to 10,400 shares worth $5.11M. The position accounts for 0.11% of the portfolio, ranked #129.

TD Private Client Wealth first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $11M in Q3 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • TD Private Client Wealth held 10,400 shares of Thermo Fisher Scientific worth $5.11M as of Q1 2026.
  • TD Private Client Wealth bought 870 Thermo Fisher Scientific shares in Q1 2026, an estimated $472K.
  • Thermo Fisher Scientific made up 0.11% of TD Private Client Wealth's portfolio in Q1 2026, its #129 holding.
  • TD Private Client Wealth first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Thermo Fisher Scientific position peaked at $11M in Q3 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.